热门资讯> 正文
Vermilion获得多伦多证券交易所关于新股票回购计划的批准
2026-07-10 00:03
- Vermilion Energy (VET) received TSX approval to launch a new normal course issuer bid.
- The company can repurchase up to 15.16M common shares, representing ~10% of its public float, from July 12, 2026, to July 11, 2027.
- Any shares repurchased under the NCIB will be cancelled, reducing the total shares outstanding.
- The company expects to return 40% of excess free cash flow to shareholders in 2026, primarily through dividends and share repurchases.
- Under its previous NCIB, Vermilion had repurchased ~1.75M shares at a weighted average price of $12.43/share as of June 30, 2026.
More on Vermilion Energy Inc.
- Vermilion Energy: Undervalued Even After A 100% Rally (Rating Downgrade)
- Vermilion Energy: The Re-Rating Story Is Far From Over
- Vermilion Energy Inc. (VET:CA) Shareholder/Analyst Call Transcript
- Vermilion Energy shares fall after quarterly net loss
- Historical earnings data for Vermilion Energy Inc.
推荐文章
港股周报 | 黄金股狂飙！灵宝黄金周升24%；段永平“被动减持”泡泡玛特；药明康德升近20%创新高
一周财经日历 | 重磅财报周！腾讯、Lumentum、中芯国际轮番登场！美国7月CPI携零售数据来袭
8月8日外盘头条：伊朗内部辩论霍尔木兹协议措辞 非农爆冷削弱加息预期 SpaceX将自建发电厂保障电力供应
Palantir股价将创下自2024年以来最佳单周表现，该股已不再是AI领域的失意者
7月非农就业数据走弱，支持美联储维持利率不变，但加息选项并未彻底排除
美股前瞻 | 聚焦20：30！市场静候7月非农数据；特朗普政府拟加码布局关键矿产；应用光电计划大规模扩产，光通信盘前集体飙升
港股异动 | 创新药概念再度走强，再鼎新药劲升14%，Q2产品收入环比增长11%；药明生物升逾5%，百济神州升逾3%
港股异动 | AI硬件股多数上涨，建滔积层板、胜宏科技涨逾5%，兆易创新涨逾3%；南方两倍做多海力士跌逾9%
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
